As per MRFR analysis, the China DNA Synthesis Market Size was estimated at 318 (USD Million) in 2023. The China DNA Synthesis Market Industry is expected to grow from 500(USD Million) in 2024 to 1,500 (USD Million) by 2035. The China DNA Synthesis Market CAGR (growth rate) is expected to be around 10.503% during the forecast period (2025 - 2035)
Key China DNA Synthesis Market Trends Highlighted
China’s DNA synthesis market is witnessing significant trends shaped by advancements in biotechnology and the increasing demand for genetic research. The Chinese government is heavily investing in biotechnology sectors, emphasizing the need for innovation and technology development, particularly in areas related to synthetic biology. This fosters an environment conducive to growth in DNA synthesis technologies, as institutions and companies seek to enhance their capabilities in genetic engineering and genomic research.
As a result, collaborations between academia and industry are becoming more prevalent, enabling the sharing of resources and knowledge, which is crucial in driving research breakthroughs.Moreover, the rising focus on personalized medicine in China presents substantial opportunities for the DNA synthesis market. With the growing emphasis on health and medical advancements, synthetic genes are increasingly used for developing tailored therapies and treatments.
The surge in clinical trials and research activities is also contributing to the growth of this market, as healthcare institutions leverage DNA synthesis for various applications, including drug development and diagnostics. A noticeable trend in recent times is the increasing adoption of automation and artificial intelligence in DNA synthesis processes. This shift is driving efficiency and accuracy, leading to a reduction in the cost and time associated with genetic research and applications.
Furthermore, China's commitment to fostering domestic biotechnology firms while restricting reliance on foreign entities enhances the competitive landscape within the local DNA synthesis market. As these trends continue to evolve, the market is positioned for sustained growth and innovation, ensuring China remains a key player within the global biotechnology arena.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
China DNA Synthesis Market Drivers
Growing Demand for Genomic Research
One major factor fueling the expansion of the China DNA Synthesis Market Industry is the rising need for genomic research. The National Medium- and Long-Term Program for Science and Technology Development (2006-2020), which provided significant money for biotechnology research, is proof that the Chinese government has been actively supporting biotechnology programs. In 2021, China spent over 2.4 percent of its GDP on research & development, which amounted to a substantial investment of almost USD 500 billion.
This commitment helps improve the fields of healthcare, agriculture, and the environment by providing substantial funding for genomic and synthetic biology research. The market is expected to increase from 2025 to 2035 due in part to the growing need to produce agricultural and customized health solutions, which is fueled by organizations such as the Chinese Academy of Sciences spearheading several genomic initiatives. The need for DNA synthesis services, which are essential for biological investigations and applications, is driven by the commensurate rise in research activity.
Increase in Genetic Disorders and Cancer Cases
The rise in genetic disorders and cancer cases in China reinforces the growth of the China DNA Synthesis Market Industry. Recent statistics from the National Health Commission indicate that the incidence of cancer in China has increased significantly, with diagnosed cancer cases exceeding 4.57 million in 2020, demonstrating a staggering rise in public health challenges. This upward trend necessitates advanced genetic analysis and therapies that often rely on DNA synthesis for effective diagnostic and treatment options.
As healthcare systems adapt to manage this increase, the demand for customized and precise therapeutic solutions is becoming imperative, thereby fueling the demand for DNA synthesis technologies within the market. The ongoing investment in oncology and genetic healthcare initiatives supports the market's forecasted growth.
Advancements in Biotechnology and Synthetic Biology
Rapid advancements in biotechnology and synthetic biology are acting as key drivers for the growth of the China DNA Synthesis Market Industry. Continued innovations in DNA synthesis technologies such as the development of high-throughput sequencing and CRISPR-Cas9 gene editingare significantly enhancing the capabilities of research institutions and biotechnology firms across China. The China National GeneBank, for instance, focuses on integrating genetic resources and technology development, which plays a pivotal role in advancing biological discoveries.
As global collaborations in synthetic biology research intensify, Chinese firms are increasingly participating in important projects, enhancing their capacity to develop novel therapeutics, biofuels, and agricultural improvements. Such advancements not only escalate the need for sophisticated DNA synthesis technologies but also suggest a promising landscape for market expansion moving forward.
China DNA Synthesis Market Segment Insights
DNA Synthesis Market Application Insights
The Application segment of the China DNA Synthesis Market is experiencing noteworthy growth driven by advancements in various fields such as Gene Therapy, Synthetic Biology, Molecular Diagnostics, and Vaccine Development. In the context of Gene Therapy, the significant advancements in genetic modification techniques are transforming treatment protocols, allowing for targeted therapies aimed at curing genetic disorders.
Meanwhile, Synthetic Biology is revolutionizing the design and engineering of biomolecules and organisms, leading to innovations in pharmaceuticals, industrial biotechnology, and environmental sustainability, thereby enhancing China's position as a global leader in biotechnology.
Molecular Diagnostics is another critical area within the market, as the demand for precise and rapid diagnostic solutions continues to increase, particularly in light of recent global health challenges. The focus on early disease detection and personalized medicine has driven growth in this sector. Vaccine Development also plays a pivotal role, showcasing China's robust capabilities in rapid vaccine production and response to emerging health threats, notably highlighted during the COVID-19 pandemic.
The ongoing research initiatives and governmental support further strengthen this domain, positioning China at the forefront of vaccine innovation on an international scale.Each of these areas not only represents a substantial share of the market but also reflects the collaborative efforts of academic institutions, government policies, and private sector investments in biotechnology.
The synergy between these applications fosters a dynamic environment where innovative solutions can emerge, addressing both health and environmental challenges. With the increasing focus on genetic research and biotechnology in the national agenda, China's DNA Synthesis Market is set to play a transformative role in advancing scientific knowledge and application toward a more sustainable and health-conscious future. This evolving landscape suggests an optimistic outlook for the various Applications within the China DNA Synthesis Market as they align with wider global trends and local priorities.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
DNA Synthesis Market Product Type Insights
The China DNA Synthesis Market is characterized by several key product types, notably Oligonucleotides, Gene Fragments, and Gene Libraries, each playing a vital role in the biotechnology landscape. Oligonucleotides are extensively used in Research and Development for applications such as PCR, sequencing, and gene editing, showcasing their significance in driving innovation in synthetic biology. Gene Fragments enable researchers to design and construct synthetic genes, facilitating advancements in areas like personalized medicine and crop engineering, thereby supporting China's push toward biotechnology self-reliance as outlined in national policies.
Gene Libraries provide a diverse collection of genetic materials that are crucial for exploring novel functions and pathways in biological research. The availability of varied genetic resources aids in enhancing productivity and efficiency in drug discovery and development. The increasing investments in biotechnology in China, along with a growing focus on genomics, enhance the importance of these product types, contributing to the broader China DNA Synthesis Market data and statistics. Factors such as a surge in demand for synthetic genes in the pharmaceutical and agricultural sectors are expected to further bolster the market growth for these prominent segments within the market landscape.
DNA Synthesis Market End User Insights
The End User segment of the China DNA Synthesis Market plays a vital role in shaping the industry landscape, encompassing Academic Research Institutions, Pharmaceutical Companies, Biotechnology Companies, and Clinical Laboratories. Academic Research Institutions are crucial for advancing genetic studies and driving innovation in DNA synthesis technologies, leveraging vast funding from various government and private sectors. Pharmaceutical Companies utilize DNA synthesis for drug discovery and development, thereby playing a significant role in addressing public health challenges in China.Meanwhile, Biotechnology Companies are focusing on harnessing synthetic biology for therapeutic applications, highlighting the growing intersection of technology and biology in driving market growth.
Clinical Laboratories increasingly rely on DNA synthesis to enhance diagnostic testing and personalized medicine approaches. As research funding in China continues to grow alongside the demand for innovative healthcare solutions, the End User segment is poised for significant expansion, fostering advancements in genetic research and therapeutic applications, which ultimately contribute to the overall China DNA Synthesis Market dynamics.The ongoing investments in genomics and biotechnology depicted in government agendas underline the importance and relevance of this segment within the broader industry.
DNA Synthesis Market Technology Insights
The Technology segment of the China DNA Synthesis Market showcases several innovative methodologies driving the industry forward. Solid-Phase Synthesis is a cornerstone technique well-regarded for its efficiency and precision in generating DNA sequences, making it particularly crucial for applications in genomics and synthetic biology. Meanwhile, Liquid-Phase Synthesis offers flexibility and scalability, accommodating a wide range of synthesis demands, which is vital as the biotech industry in China continues to expand. PCR-Based Synthesis stands out for its capability to amplify specific DNA sequences, supporting various research and clinical applications, and is essential in the landscape of molecular biology.
The market is poised for significant growth, with advancements in these technologies contributing to the burgeoning demand for customized and high-throughput DNA synthesis services. The ongoing trend of increased investment in Research and Development within China further propels these methodologies, enabling innovation and adaptations that align with international standards. As the biotechnology sector evolves, understanding the dynamics of these synthesis technologies will be pivotal in addressing the unique demands of the China DNA Synthesis Market.
China DNA Synthesis Market Key Players and Competitive Insights
The China DNA Synthesis Market has shown significant growth over recent years, fueled by advancements in biotechnology and increasing research activity in genomics and synthetic biology. This market is characterized by fierce competition as numerous companies strive to dominate the landscape, capitalizing on the growing demand for synthetic DNA in various applications, such as drug development, agriculture, and diagnostics. The competition is driven by technological innovations, pricing strategies, and the ability to offer customized solutions that cater to a broad range of customer needs. Market participants are not only focused on expanding their product portfolios but also on enhancing their operational efficiencies and reaching new customer segments.
Therefore, understanding the competitive dynamics within this market is critical for stakeholders aiming to achieve sustainable growth and maintain a competitive edge.Thermo Fisher Scientific holds a robust position in the China DNA Synthesis Market due to its extensive range of products and services tailored for genetic research and applications. The company is recognized for its state-of-the-art technology, which facilitates high-throughput DNA synthesis and analysis. Additionally, Thermo Fisher Scientific benefits from a wide distribution network in China, enabling quick and efficient delivery of its products to various research institutions and laboratories across the country.
The company’s strength lies in its commitment to innovation, investing heavily in research and development to introduce cutting-edge solutions that meet the evolving needs of its customers in the rapidly advancing field of genomics. This focus, coupled with strategic partnerships and collaborations with local research entities, has significantly bolstered its market presence in China.Molecular Devices has established a notable presence in the China DNA Synthesis Market, recognized for its innovative technology and comprehensive product offerings that encompass a range of instrumentation and software solutions used in life sciences and drug discovery.
The company is particularly known for its specialized systems that improve the efficiency and accuracy of DNA synthesis processes. In recent years, Molecular Devices has expanded its capabilities through strategic mergers and acquisitions, allowing it to integrate advanced technologies and broaden its market reach in China. This strategy has enhanced its operational proficiency and product range, making it a significant player in the region.
The company’s strengths also include a strong customer support framework, which provides users with essential assistance and training, thereby enhancing customer satisfaction and loyalty towards their products and services.
Key Companies in the China DNA Synthesis Market Include
China DNA Synthesis Market Industry Developments
The China DNA Synthesis Market has seen significant advancements and developments in recent months, underscored by a growing demand for synthetic DNA in research and therapeutic applications. Companies such as Thermo Fisher Scientific and GenScript are expanding their presence through collaborations and partnerships aimed at enhancing their product offerings within the region. In June 2023, Synthego announced plans to increase its operational capacity in China, tapping into the region's burgeoning biotechnology sector. The market is experiencing notable growth, with significant investments observed from firms like Twist Bioscience and Integrated DNA Technologies, aiming to bolster their market share in China.
Additionally, in August 2023, OriGene Technologies reported a strategic merger with a local biotech firm to enhance its research capabilities, reflecting the increasing trend of consolidation within the industry. Companies are focusing on cutting-edge technologies, with molecular diagnostic applications driving demand. Furthermore, the Chinese government has been supportive, implementing policies that stimulate research and innovation in biotechnology, making the country an attractive hub for both domestic and international players. These factors are reshaping the landscape of the DNA synthesis market in China, fostering a dynamic environment for growth and innovation in the sector.
China DNA Synthesis Market Segmentation Insights
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2023 | 318.0(USD Million) |
| MARKET SIZE 2024 | 500.0(USD Million) |
| MARKET SIZE 2035 | 1500.0(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 10.503% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Million |
| KEY COMPANIES PROFILED | Thermo Fisher Scientific, Molecular Devices, Zymergen, IDT, Synthego, Bioneer, OriGene Technologies, Twist Bioscience, Sangamo Therapeutics, GenScript, Synlogic, Epoch Biolabs, GeneArt, Integrated DNA Technologies, LGC Limited |
| SEGMENTS COVERED | Application, Product Type, End User, Technology |
| KEY MARKET OPPORTUNITIES | Increasing demand for personalized medicine, Expanding synthetic biology applications, Growth in academic research funding, Advancements in gene editing technologies, Rising biopharma industry needs |
| KEY MARKET DYNAMICS | Increasing research funding, Growing biotech industry, Rising demand for synthetic biology, Advancements in sequencing technology, Expanding applications in healthcare |
| COUNTRIES COVERED | China |
Frequently Asked Questions (FAQ) :
The projected market size of the China DNA Synthesis Market in 2024 is expected to be valued at 500.0 USD Million.
By 2035, the China DNA Synthesis Market is expected to grow to a valuation of 1500.0 USD Million.
The expected CAGR for the China DNA Synthesis Market from 2025 to 2035 is 10.503%.
The major applications of the China DNA Synthesis Market include Gene Therapy, Synthetic Biology, Molecular Diagnostics, and Vaccine Development.
The Gene Therapy application is expected to be valued at 150.0 USD Million in 2024.
The forecasted market value for the Synthetic Biology application is expected to reach 375.0 USD Million by 2035.
Key players in the China DNA Synthesis Market include Thermo Fisher Scientific, Molecular Devices, Zymergen, IDT, and Synthego among others.
The projected market value of Molecular Diagnostics in 2024 is 130.0 USD Million.
The Vaccine Development segment is expected to be valued at 285.0 USD Million by 2035.
Notable growth drivers for the China DNA Synthesis Market include the increasing demand for advanced molecular diagnostics and the growth of synthetic biology sectors.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
